Your browser doesn't support javascript.
loading
Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.
Zhang, Feifei; Tang, Xiaofeng; Fan, Song; Liu, Xia; Sun, Jun; Ju, Cheng; Liang, Yiping; Liu, Renfeng; Zhou, Ruihao; Yu, Bo; Zhang, Changhua; Zhang, Zhiping; Kang, Tiebang; Huang, Guofu; Lv, Xiao-Bin.
Affiliation
  • Zhang F; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Tang X; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Fan S; Department of Oral and Maxillofacial Surgery, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, PR China.
  • Liu X; Department of Medical Oncology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, PR China.
  • Sun J; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Ju C; College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, PR China.
  • Liang Y; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Liu R; Department of Orthopedics, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.
  • Zhou R; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Yu B; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Zhang C; Department of Orthopedics, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.
  • Zhang Z; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Kang T; Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Central Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, PR China.
  • Huang G; Department of Orthopedics, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China.
  • Lv XB; College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, PR China.
Oncogene ; 40(24): 4137-4150, 2021 06.
Article in En | MEDLINE | ID: mdl-34017080
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / DNA-Binding Proteins / E1A-Associated p300 Protein / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2021 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / DNA-Binding Proteins / E1A-Associated p300 Protein / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2021 Document type: Article Country of publication: United kingdom